Alnylam Pharmaceuticals (ALNY) Shareholder's Equity Growth (5y) (2014 - 2026)
Alnylam Pharmaceuticals (ALNY) Shareholder's Equity Growth (5y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Alnylam Pharmaceuticals |
37.52 Bn |
34.51 Bn |
959.66 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
3.03% |
| Dec 31, 2025 |
-4.93% |
| Sep 30, 2025 |
-28.07% |
| Jun 30, 2025 |
-29.11% |
| Mar 31, 2025 |
-20.59% |
| Dec 31, 2024 |
-45.83% |
| Sep 30, 2024 |
-54.21% |
| Jun 30, 2024 |
-14.89% |
| Mar 31, 2024 |
-16.45% |
| Dec 31, 2023 |
-16.75% |
| Sep 30, 2023 |
-16.13% |
| Jun 30, 2023 |
-17.63% |
| Mar 31, 2023 |
-16.52% |
| Dec 31, 2022 |
-15.88% |
| Sep 30, 2022 |
-15.59% |
| Jun 30, 2022 |
-30.97% |
| Mar 31, 2022 |
-13.55% |
| Dec 31, 2021 |
-8.56% |
| Sep 30, 2021 |
-5.72% |
| Jun 30, 2021 |
-4.92% |
